Research and Markets (http://www.researchandmarkets.com/research/xm6hdm/orphan_diseases) has announced the addition of the "Orphan Diseases Pipeline Database - 2016" report to their offering.

Orphan Diseases Pipeline Highlights Database - 2016, provides most up-to-date information on key pipeline molecules in the global Orphan Diseases Drug market. It covers emerging therapies for Orphan Diseases in active clinical development stages including early and late stage clinical trials. The pipeline data is presented in an excel dashboard with filtering options.

The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

By Indication:

The report presents pipeline by Orphan Diseases indications.

By Clinical Trial Stages:

The report provides Orphan Diseases pipeline molecules by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

By Drug Mechanism Classes:

The report provides Orphan Diseases pipeline molecules by their dominant drug mechanism class. This helps executives categorize molecules based on their drug class and also assess the strengths and weaknesses of compounds.

By Company:

The report provides Orphan Diseases pipeline molecules by the developing company and the partnered company.

SUMMARY:

- Orphan Diseases Pipeline by Indication

- Orphan Diseases Pipeline by Clinical Trial Phase

- Orphan Diseases Pipeline by Drug Mechanism Classes

- Orphan Diseases Pipeline by Company

For more information visit http://www.researchandmarkets.com/research/xm6hdm/orphan_diseases